NDA Help Center

Login Dialog

Frequently Asked Questions

Glossary

NDA Help Center

Filter Cart

The Filter Cart provides a powerful way to query and access data for which you may be interested.  

A few points related to the filter cart are important to understand with the NDA Query/Filter implementation: 

First, the filter cart is populated asyncronously.  So, when you run a query, it may take a moment to populate but this will happen in the background so you can define other queries during this time.  

When you are adding your first filter, all data associated with your query will be added to the filter cart (whether it be a collection, a concept, a study, a data structure/elment or subjects). Not all data structures or collections will necessarily be displayed.  For example, if you select the NDA imaging structure image03, and further restrict that query to scan_type fMRI, only fMRI images will appear and only the image03 structure will be shown.  To see other data structures, select "Find All Subject Data" which will query all data for those subjects. When a secord or third filter is applied, an AND condition is used.  A subject must exist in all filters.  If the subject does not appear in any one filter, that subjects data will not be included in your filter cart. If that happens, clear your filter cart, and start over.  

It is best to package more data than you need and access those data using other tools, independent of the NDA (e.g. miNDAR snapshot), to limit the data selected.  If you have any questions on data access, are interested in using avaialble web services, or need help accessing data, please contact us for assistance.  

Frequently Asked Questions

Glossary

Loading...

Login
Reset Password

NDA provides a single access to de-identified autism research data. For permission to download data, you will need an NDA account with approved access to NDA or a connected repository (AGRE, IAN, or the ATP). For NDA access, you need to be a research investigator sponsored by an NIH recognized institution with federal wide assurance. See Request Access for more information.

Warning Notice

This is a U.S. Government computer system, which may be accessed and used only for authorized Government business by authorized personnel. Unauthorized access or use of this computer system may subject violators to criminal, civil, and/or administrative action. All information on this computer system may be intercepted, recorded, read, copied, and disclosed by and to authorized personnel for official purposes, including criminal investigations. Such information includes sensitive data encrypted to comply with confidentiality and privacy requirements. Access or use of this computer system by any person, whether authorized or unauthorized, constitutes consent to these terms. There is no right of privacy in this system.

Update Password

You have logged in with a temporary password. Please update your password. Passwords must contain 8 or more characters and must contain at least 3 of the following types of characters:

  • Uppercase
  • Lowercase
  • Numbers
  • Special Characters limited to: %,_,!,@,#,$,-,%,&,+,=,),(,*,^,:,;

Subscribe to our mailing list

Mailing List(s)
Email Format

You are now leaving the NIMH Data Archive (NDA) web site to go to:

Click on the address above if the page does not change within 10 seconds.

Disclaimer

NDA is not responsible for the content of this external site and does not monitor other web sites for accuracy.

Accept Terms
Filter Cart
No filters selected
Description
Value Range
Notes
Data Structures with shared data
No filters have been selected
Switch User

Concomitant Treatment

alltx

01

Download Definition as
Download Submission Template as
Element NameData TypeSizeRequiredDescriptionValue RangeNotesAliases
subjectkeyGUIDRequiredThe NDAR Global Unique Identifier (GUID) for research subjectNDAR*
src_subject_idString20RequiredSubject ID how it's defined in lab/projectpatid, randid, subjid
interview_dateDateRequiredDate on which the interview/genetic test/sampling/imaging/biospecimen was completed. MM/DD/YYYYRequired field
interview_ageIntegerRequiredAge in months at the time of the interview/test/sampling/imaging.0 :: 1260Age is rounded to chronological month. If the research participant is 15-days-old at time of interview, the appropriate value would be 0 months. If the participant is 16-days-old, the value would be 1 month.
sexString20RequiredSex of the subjectM;FM = Male; F = Femalegender
stageIntegerRecommendedStudy stage
0::5; 51::53; 67; -888; -999
0 = Pre-Randomization (TADS) 1 = Stage 1 (TADS) 2 = Stage 2 (TADS) 3 = Stage 3 (TADS) 4 = Stage 4 (TADS) 5 = Stage 5 (SOFTAD); 51=Treatmentas Usual; 52=Screening Alone; 53=Intervention; 67=Unknown; -888=Not Applicable; -999=Missing;
pmtgrpString10RecommendedPremature Termination Categoryno;s1;s1s;s2;s3no = no PMT; s1 = Stage 1 PMT; s1s = Stage 1 Switcher; s2 = Stage 2 PMT; s3 = Stage 3 PMT
drpgrpString10RecommendedStudy Drop Categoryno;s1;s2;s3no = no Drop; s1 = Stage 1 Drop; s2 = Stage 2 Drop; s3 = Stage 3 Drop
tads_flxIntegerRecommendedIndicator of whether patient received a non-ASAP PT session during the stage (only counting sessions where it was clear the patient had been on drug on the session date).Note: This assumes that all PBO patients received FLX after Stage I PMT if PT sessions continued.0;10 = No; 1 = Yes
tads_cbtIntegerRecommendedIndicator of whether patient received a non-ASAP CBT session during the stage.0;10 = No; 1 = Yes
ntc_tt1IntegerRecommendedFirst non-TADS treatment type (based on alphabetical text listing of treatment received) prescribed in the stage.1::81 = Anti-depressant; 2 = Stimulant; 3 = Anti-anxiety; 4 = Neuroleptic; 5 = Mood stabilizer; 6 = Other medication; 7 = CBT; 8 = Other psychosocial
ntc_tt2IntegerRecommendedSecond non-TADS treatment type (based on alphabetical text listing of treatment received) prescribed in the stage.1::81 = Anti-depressant; 2 = Stimulant; 3 = Anti-anxiety; 4 = Neuroleptic; 5 = Mood stabilizer; 6 = Other medication; 7 = CBT; 8 = Other psychosocial
ntc_tt3IntegerRecommendedThird non-TADS treatment type (based on alphabetical text listing of treatment received) prescribed in the stage.1::81 = Anti-depressant; 2 = Stimulant; 3 = Anti-anxiety; 4 = Neuroleptic; 5 = Mood stabilizer; 6 = Other medication; 7 = CBT; 8 = Other psychosocial
ntc_tt4IntegerRecommendedFourth non-TADS treatment type (based on alphabetical text listing of treatment received) prescribed in the stage.1::81 = Anti-depressant; 2 = Stimulant; 3 = Anti-anxiety; 4 = Neuroleptic; 5 = Mood stabilizer; 6 = Other medication; 7 = CBT; 8 = Other psychosocial
ntc_tt5IntegerRecommendedFifth non-TADS treatment type (based on alphabetical text listing of treatment received) prescribed in the stage.1::81 = Anti-depressant; 2 = Stimulant; 3 = Anti-anxiety; 4 = Neuroleptic; 5 = Mood stabilizer; 6 = Other medication; 7 = CBT; 8 = Other psychosocial
ntc_tt6IntegerRecommendedSixth non-TADS treatment type (based on alphabetical text listing of treatment received) prescribed in the stage.1::81 = Anti-depressant; 2 = Stimulant; 3 = Anti-anxiety; 4 = Neuroleptic; 5 = Mood stabilizer; 6 = Other medication; 7 = CBT; 8 = Other psychosocial
ntc_tt7IntegerRecommendedSeventh non-TADS treatment type (based on alphabetical text listing of treatment received) prescribed in the stage.1::81 = Anti-depressant; 2 = Stimulant; 3 = Anti-anxiety; 4 = Neuroleptic; 5 = Mood stabilizer; 6 = Other medication; 7 = CBT; 8 = Other psychosocial
ntc_tt8IntegerRecommendedEighth non-TADS treatment type (based on alphabetical text listing of treatment received) prescribed in the stage.1::81 = Anti-depressant; 2 = Stimulant; 3 = Anti-anxiety; 4 = Neuroleptic; 5 = Mood stabilizer; 6 = Other medication; 7 = CBT; 8 = Other psychosocial
ntc_adepIntegerRecommendedIndicator of whether any prescribed treatment in the stage was anti-depressant medication.11 = Yes
ntc_stimIntegerRecommendedIndicator of whether any prescribed treatment in the stage was stimulant medication.11 = Yes
ntc_aanxIntegerRecommendedIndicator of whether any prescribed treatment in the stage was anti-anxiety medication.11 = Yes
ntc_neurIntegerRecommendedIndicator of whether any prescribed treatment in the stage was neuroleptic medication.11 = Yes
ntc_moodIntegerRecommendedIndicator of whether any prescribed treatment in the stage was mood stabilizing medication.11 = Yes
ntc_othmIntegerRecommendedIndicator of whether any prescribed treatment in the stage was a medication other than those already classified.11 = Yes
ntc_cbtIntegerRecommendedIndicator of whether any prescribed treatment in the stage was cognitive behavioral therapy.11 = Yes
ntc_othpIntegerRecommendedIndicator of whether any prescribed treatment in the stage was an other psychosocial therapy.11 = Yes
c_iphIntegerRecommendedIndicator of whether patient used an inpatient unit in a psychiatric hospital during the stage.11 = Yes
c_ighIntegerRecommendedIndicator of whether patient used an inpatient psychiatric unit in a general hospital during the stage.11 = Yes
c_idrgIntegerRecommendedIndicator of whether patient used an inpatient alcohol or drug treatment or detox unit during the stage.11 = Yes
c_iemoIntegerRecommendedIndicator of whether patient used a regular medical inpatient unit for emotional, behavior, or substance use problems during the stage.11 = Yes
c_restIntegerRecommendedIndicator of whether patient used a residential treatment center during the stage.11 = Yes
c_grphIntegerRecommendedIndicator of whether patient used a group home during the stage.11 = Yes
c_dayIntegerRecommendedIndicator of whether patient used a day hospital/day treatment during the stage.11 = Yes
c_fostIntegerRecommendedIndicator of whether patient used therapeutic foster care during the stage.11 = Yes
c_odrgIntegerRecommendedIndicator of whether patient used an outpatient drug or alcohol unit during the stage.11 = Yes
c_cmanIntegerRecommendedIndicator of whether patient used case management coordination during the stage.11 = Yes
c_homeIntegerRecommendedIndicator of whether patient used in-home counseling or crisis services during the stage.11 = Yes
c_proIntegerRecommendedIndicator of whether patient used professional treatment during the stage.11 = Yes
c_docIntegerRecommendedIndicator of whether patient used a medical doctor during the stage.11 = Yes
c_erIntegerRecommendedIndicator of whether patient used an emergency room during the stage.11 = Yes
c_hotIntegerRecommendedIndicator of whether patient used a crisis hotline during the stage.11 = Yes
c_othIntegerRecommendedIndicator of whether patient used other services during the stage.11 = Yes
ssrimedIntegerRecommendedNon-TADS SSRI use0;10 = No; 1 = Yes
daysrzIntegerRecommendeddays since randomizationvisitdt
studyString100RecommendedStudystudyid
siteString101RecommendedSiteStudy Sitesiteid
visitString50RecommendedVisit nameint1, timept
completedIntegerRecommendedChecks if completed0::30=No; 1=Yes; 2=Yes, lost; 3=Unverifiedformcomp
subtrial_nameIntegerRecommendedName of subtrial1::31=Crossover; 2=Guanfacine; 3= Open Label MPH
pmtotIntegerRecommendedTotal pagescttot
ctanyIntegerRecommendedTreatments other than meds0;10=No; 1=Yes
pmmednumIntegerRecommendedMedication/treatment numberfi_dcode, trtnum
treatment_nameString200Recommendedtreatment namectname, fi_dname, fi_nname, treatment
cttaeIntegerRecommendedTreatment for an AE0;10=No; 1=Yes
aef001IntegerRecommendedAdverse Event number-9=unknownctaenum
pmstdtIntegerRecommendedDate medication/treatment began in days from the randomization datectstdt, daystart_t
cmcontIntegerRecommendedContinuing at end of study?1;21=Yes; 2=Noctcont
pmstopIntegerRecommendedDate medication/treatment stopped in days from the randomization datectstop, dayend_t
visdayIntegerRecommendedNumber of days from study baseline to date of visitdayctl_t, vdaconm
slot_tIntegerRecommendedSlot on Concomitant Treatment Log formfi_drln, fi_ndrln
page_tIntegerRecommendedPage of Concomitant Treatment Log form
mhIntegerRecommendedIs Concomitant Treatment a mental health treatment?0;10 = No;1 = Yes
indicationString50RecommendedIndication for which Concomitant Treatment usedfi_dindi, fi_nindi
cont_tIntegerRecommendedIs Concomitant Treatment still being used?0;10 = No;1 = Yesfi_dongo, fi_nongo
study_idIntegerRecommendedStudy ID number46=Acute Phase; 47=Stabilization Phase
procedureString200RecommendedConcomitant Procedures
startdyIntegerRecommendedStart Daycdtstda, ndotstda, startdays
enddayIntegerRecommendedStop Daycdtspda, ndotspda, stopdays
fi_ckdrgIntegerRecommendedNo concomitant medications0;10 = No;1 = Yes
fi_ckndrIntegerRecommendedNo concomitant non-drug treatment0;10 = No;1 = Yes
saps_ad10IntegerRecommendedRater number
fi_freqString35RecommendedConcomitant treatment frequencyfi_nsess
q14_unitString10RecommendedDose: UnitIn mg, tsp, pills, etc.fi_unit
q14_qtyFloatRecommendedDose: Quantity0.0 :: 325; -7; -8; -9;999-7 = Don't know; -8 = Refused to answer; -9 = Does not apply; 999 = Missing valuefi_dose
route1String50Recommendedroute 1
conmednoIntegerRecommendedCheck if NO concomitant medications were used0;10=No; 1=Yes
cntr_othrtrtIntegerRecommendedReceived any treatments other than medic1;21=Yes;2=No
visnumFloatRecommendedNumeric Visit Number-1.5 = Pre-Screening; -1 = Screening; 0 = Baseline; ## = Visit ## (from 1 to 10); Whole numbers = standard monthly visits; #.001 - #.009 = Unscheduled; #.1 = End of Phase 1; #.2 = End of Phase 2; #.3 = End of Phase 3; #.4 = End of Open Choice Phase; #.5 = End of Study; #.6 = Genetic Analysis; 1000=all visits
anytrtmntIntegerRecommendedHas the subject received medical treatment other than drugs 30 days prior to or during this study?0;10 = No; 1 = Yes
cmindString200RecommendedIndication
cmstrtdtDateRecommendedStart Date
cmstpdtDateRecommendedStop Date
Data Structure

This page displays the data structure defined for the measure identified in the title and structure short name. The table below displays a list of data elements in this structure (also called variables) and the following information:

  • Element Name: This is the standard element name
  • Data Type: Which type of data this element is, e.g. String, Float, File location.
  • Size: If applicable, the character limit of this element
  • Required: This column displays whether the element is Required for valid submissions, Recommended for valid submissions, Conditional on other elements, or Optional
  • Description: A basic description
  • Value Range: Which values can appear validly in this element (case sensitive for strings)
  • Notes: Expanded description or notes on coding of values
  • Aliases: A list of currently supported Aliases (alternate element names)
  • For valid elements with shared data, on the far left is a Filter button you can use to view a summary of shared data for that element and apply a query filter to your Cart based on selected value ranges

At the top of this page you can also:

  • Use the search bar to filter the elements displayed. This will not filter on the Size of Required columns
  • Download a copy of this definition in CSV format
  • Download a blank CSV submission template prepopulated with the correct structure header rows ready to fill with subject records and upload

Please email the The NDA Help Desk with any questions.

Distribution for DataStructure: alltx01 and Element:
Chart Help

Filters enable researchers to view the data shared in NDA before applying for access or for selecting specific data for download or NDA Study assignment. For those with access to NDA shared data, you may select specific values to be included by selecting an individual bar chart item or by selecting a range of values (e.g. interview_age) using the "Add Range" button. Note that not all elements have appropriately distinct values like comments and subjectkey and are not available for filtering. Additionally, item level detail is not always provided by the research community as indicated by the number of null values given.

Filters for multiple data elements within a structure are supported. Selections across multiple data structures will be supported in a future version of NDA.